Ipca Laboratories standalone net profit declines 27.11% in the March 2022 quarter

Sales rise 12.25% to Rs 1168.45 crore

Net profit of Ipca Laboratories declined 27.11% to Rs 110.41 crore in the quarter ended March 2022 as against Rs 151.48 crore during the previous quarter ended March 2021. Sales rose 12.25% to Rs 1168.45 crore in the quarter ended March 2022 as against Rs 1040.92 crore during the previous quarter ended March 2021.

For the full year,net profit declined 23.65% to Rs 870.94 crore in the year ended March 2022 as against Rs 1140.77 crore during the previous year ended March 2021. Sales rose 5.06% to Rs 5399.36 crore in the year ended March 2022 as against Rs 5139.16 crore during the previous year ended March 2021.

ParticularsQuarter EndedYear EndedMar. 2022Mar. 2021% Var.Mar. 2022Mar. 2021% Var.Sales1168.451040.92 12 5399.365139.16 5 OPM %15.3220.81 -23.0329.45 - PBDT190.02234.24 -19 1292.461567.68 -18 PBT137.63185.67 -26 1088.361379.96 -21 NP110.41151.48 -27 870.941140.77 -24

Powered by Capital Market - Live News